EL
Essex LLC’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,430
| Closed | -$967K | – | 174 |
|
|
2024
Q2 | $967K | Sell |
10,430
-435
| -4% | -$40.3K | 0.22% | 79 |
|
|
2024
Q1 | $1.03M | Sell |
10,865
-1,122
| -9% | -$106K | 0.24% | 77 |
|
|
2023
Q4 | $1.07M | Sell |
11,987
-7,122
| -37% | -$636K | 0.27% | 77 |
|
|
2023
Q3 | $1.4M | Sell |
19,109
-7,318
| -28% | -$534K | 0.39% | 64 |
|
|
2023
Q2 | $2.2M | Sell |
26,427
-3,887
| -13% | -$323K | 0.61% | 47 |
|
|
2023
Q1 | $2.52M | Hold |
30,314
| – | – | 0.76% | 43 |
|
|
2022
Q4 | $2.52M | Sell |
30,314
-5
| -0% | -$415 | 0.76% | 43 |
|
|
2022
Q3 | $2.41M | Buy |
30,319
+5,541
| +22% | +$440K | 0.79% | 44 |
|
|
2022
Q2 | $1.84M | Sell |
24,778
-822
| -3% | -$61K | 0.57% | 58 |
|
|
2022
Q1 | $2.3M | Buy |
25,600
+2,026
| +9% | +$182K | 0.62% | 52 |
|
|
2021
Q4 | $2.64M | Buy |
23,574
+1,970
| +9% | +$221K | 0.71% | 46 |
|
|
2021
Q3 | $2.72M | Buy |
+21,604
| New | +$2.72M | 0.75% | 45 |
|